The valuations of some US companies still in ‘start-up mode’ is amazing.
https://www.forbes.com/sites/elanag...osing-200-million-funding-round/#a1ad238345ee
HMS could have chosen any number of US companies to invest and partner with but selected MedAdvisor.
Management have stated there’s many other opportunities with HMS beyond the initial Eliza launch later this year.
Once there’s actual revenue coming in, the share price should open up a bit up, else it’s all just ‘forecasted’, ‘pending’, ‘scheduled’. Unfortunately all these terms are recognised as zero on a balance sheet.
The valuations of some US companies still in ‘start-up mode’ is...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MDR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
41.0¢ |
Change
0.020(5.13%) |
Mkt cap ! $226.0M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 41.5¢ | 39.0¢ | $240.8K | 603.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 41.5¢ | 7692 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MDR (ASX) Chart |